Posts
>Sun Pharma(RELIGARE SECURITIES)
To read full report
Sun Pharma(RELIGARE SECURITIES)
skip to main |
skip to sidebar
Research Reports on Stocks, Commodities, Forex & Market Strategies
Followers
Other useful Blogs
Post Archive
- ► 2012 (962)
- ► 2010 (937)
- ► 2009 (2414)
Research Houses
- AADHAR SECURITIES (1)
- AASPL (4)
- ABN AMRO (1)
- ACQUISITIONS (2)
- ADB (1)
- ADITYA BIRLA MONEY LIMITED (6)
- AIG INVESTMENTS (1)
- ALCHEMY (4)
- ALMONDZ (2)
- AMBIT CAPITAL (25)
- AMSEC (1)
- ANAGRAM (64)
- Anand Rathi (57)
- ANGEL BROKING (60)
- ANTIQUE (25)
- ANZ (2)
- APNA MONEY (1)
- ARM RESEARCH (2)
- ARTICLES (6)
- ASIT C MEHTA (4)
- AVENDUS (10)
- BAJAJ CAPITAL (1)
- BARCLAYS CAPITAL (7)
- BATLIVALA KARANI (2)
- BCA (1)
- BENCHMARK (1)
- BHARTI AXA (1)
- BIRLA SUN LIFE (2)
- BNP PARIBAS (43)
- BONANZA (11)
- BOOZ COMPANY (1)
- BOSTON CONSULTING GROUP (1)
- BP WEALTH EQUITIES (5)
- BRICS (10)
- CANARA ROBECO (1)
- CAPEGEMINI (2)
- CAPITAL ECONOMICS (1)
- CARE RESEARCH (12)
- CASEY RESEARCH (1)
- CD EQUIRESEARCH (5)
- CENTRUM (150)
- Cholamandalam securities limited (9)
- CIBC (5)
- CICC (1)
- CITI (279)
- CITICS SECURITIES (1)
- CLSA (90)
- COMMODITY (121)
- COWEN (1)
- CRISIL (23)
- CURRENT ISSUES (44)
- CUSHMAN WAKEFIELD (1)
- CYGNUS (3)
- DAIWA (5)
- Danske Markets (16)
- DATAMONITOR (1)
- DBS (15)
- DELOITTE (2)
- DESTIMONEY (1)
- DEUTSCHE BANK (47)
- DHANLAXMI BANK (1)
- DOLAT CAPITAL (24)
- DSP BLACKROCK (1)
- EAST SECURITIES INDIA LIMITED (1)
- ECLAIRAGES (3)
- ECONOMIC INDICATORS (1)
- ECONOMIC RESEARCH (67)
- EDELWEISS (150)
- EDUCATION (1)
- ELARA CAPITAL (9)
- EMKAY (79)
- ENAM Securities (13)
- EQUIRUS (3)
- EQUITY RESEARCH (3)
- ERNST YOUNG (1)
- Escorts (1)
- ESPIRITO SANTO (5)
- FAIRWEALTH (11)
- Financepedia (11)
- FINQUEST (12)
- FIRST CALL (28)
- FIRST GLOBAL (30)
- FIT (1)
- FITCH RATINGS (5)
- FOREX (4)
- FULLERTON (5)
- GDP (1)
- GEOJIT (9)
- GEPL (32)
- GLOBAL MARKET RESEARCH (3)
- GOLDMAN SACH (90)
- HAYMAN (1)
- HDFC Securities (65)
- HEDGE EQUITIES (7)
- HEERNET VENTURES (2)
- HEM SECURITIES (13)
- HSBC (122)
- ICICI Direct (280)
- ICICI Securities (89)
- ICRA (4)
- IDBI CAPITAL (5)
- IDFC SSKI (66)
- IFIN RESEARCH (1)
- IIFL (30)
- IMF (1)
- INAJ MENA (1)
- INDEC SECURITIES (1)
- INDIA CAPITAL MARKETS (9)
- INDIA INFOLINE (87)
- INDIABULLS (36)
- IndiaNivesh (3)
- ING INVESTMENT MANAGEMENT INDIA (1)
- ING VYSYA (1)
- INSURANCE (2)
- Investsmart (3)
- IPO (19)
- Jaypee Capital (11)
- JEFFERIES (7)
- JM FINANCIAL (21)
- JOURNALS (1)
- JP MORGAN (61)
- KARVY (50)
- KIM ENG (1)
- KJMC Insitutional Research (3)
- KOTAK SECURITIES (74)
- KPMG (13)
- KR CHOKSEY (39)
- KREDENT FINANCE (16)
- KSL (1)
- LKP SHARES (25)
- LLOYDS TSB (1)
- MAC (1)
- Macquarie Research (78)
- MAIA FINANCIAL SERVICES (1)
- Mammon Capital (1)
- MANSUKH (3)
- MARWADI FINANCIAL (58)
- McKinsey (12)
- MERRILL LYNCH (167)
- MF GLOBAL (17)
- MICROSEC (17)
- Misc (2)
- MOODY'S (2)
- Morgan Stanley (201)
- MOTILALOSWAL (120)
- MUTUAL FUNDS (6)
- NATIXIS (32)
- NETWORTH CAPITAL (5)
- NIRMAL BANG (32)
- Noble Research (6)
- NOMURA (84)
- OSK GROUP (1)
- P-SEC (1)
- PHILLIP CAPITAL (1)
- PIMCO (1)
- PINC RESEARCH (17)
- PPFAS (5)
- PRABHUDAS LILLADHER (64)
- PRESS RELEASE (1)
- PRICEWATERHOUSE COOPERS (2)
- PRIME BROKING (4)
- QUANTUM (1)
- R K GLOBAL (1)
- RBI (1)
- RBS (13)
- RELIANCE Equities (9)
- RELIANCE MONEY (24)
- RELIANCE SECURITIES (4)
- RELIGARE SECURITIES (72)
- RESULTS (16)
- RESULTS PREVIEW (3)
- REUTERS (1)
- RK GLOBAL (1)
- RR (1)
- RR FINANCIAL (3)
- SBIcap securities (12)
- SCHRODERS (1)
- SHAREKHAN (149)
- SICO RESEARCH (1)
- SKP (7)
- SMC (18)
- SOCIETE GENRALE (3)
- SPA (10)
- SPARK CAPITAL (3)
- STANDARD CHARTERED (7)
- STANDARD POOR'S (1)
- STRATEGIES (46)
- SUNIDHI (27)
- SUSHIL FINANCE (6)
- SYSTEMATIX RESEARCH (7)
- TATA SECURITIES (8)
- TD SECURITIES (2)
- TECHNO GROUP (3)
- THE WALL STREET JOURNAL (1)
- UBS (54)
- ULJK SECURITIES (8)
- UNCTAD (2)
- UNICON INVESTMENTS (6)
- VENTURA (9)
- WACHOVIA (2)
- WALLFORT (1)
- WAY2WEALTH (15)
- WELLS FARGO LIMITED (10)
- WHARTON (4)
- WHITE PAPERS (6)
0 comments:
Post a Comment